Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic sibling umbilical cord blood nuclear cell infusion for children with cerebral palsy or cerebral disorder (Allo-CBRek)
jRCTa060200018Completed
- Start
- Oct 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of sibling allogenic umbilical cord blood nuclear cells in cerebral palsy (CP) and hypoxic-ischemic encephalopathy (HIE). Started Oct 2020; status: completed.
02
Drugs
sibling allogenic umbilical cord blood nuclear cells
03
Conditions
cerebral palsy (CP)hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on jRCTa060200018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTa060200018.